Tradestie Institutional Equity Comparison Engine

MCHPP vs AXTI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AXTI Overall Edge

AXTI Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AXT Inc (AXTI) driven by superior Valuation, Momentum & Technical, Options & Structure while MCHPP counters with relative strength in Growth & Margin. Fundamentally, MCHPP trades at N/M Forward P/E with 21.6% operating margin (+42.2% YoY revenue) versus AXTI at 16.4x Forward P/E and 19.6% operating margin (+162.6% YoY). In options structure, MCHPP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AXTI sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AXTI
MCHPP N/M vs AXTI 16.4x Fwd P/E
Growth & Margin Winner MCHPP
Op Margin 21.6% vs 19.6% ยท YoY +42.2% vs +162.6%
Momentum & Technical Winner AXTI
1Y +0.8% vs +265.6% ยท 52W Pos 14% vs 22%
Options & Structure Winner AXTI
UNCLASSIFIED (N/A IV) vs BREAKDOWN (13th %ile IV)
MCHPP NASDAQ
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock
Semiconductors & Related Devices
$52.64
-3.18% 1D
Market Cap N/A
1M Return -17.41%
1Y Return +0.8%
Forward P/E N/M
Unified AI Score
57.1 / 100 HOLD
Tech 74.0 Fund 61.0 Flow 50.0 Mom 60.0
AXTI NASDAQ
AXT Inc
Semiconductors & Related Devices
$38.16
-8.78% 1D
Market Cap $2.9B
1M Return -25.85%
1Y Return +265.57%
Forward P/E 16.4x
Unified AI Score
54.2 / 100 HOLD
Tech 50.0 Fund 52.0 Flow 70.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MCHPP +0.8% AXTI +265.57% Spread: +264.77 pp (AXTI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MCHPP TTM Op. Margin: 21.6% AXTI TTM Op. Margin: 19.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MCHPP vs AXTI. Trailing 12-month operating profitability (MCHPP 21.6% vs AXTI 19.6%) and valuation multiples (MCHPP N/M vs AXTI 16.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MCHPP (4) vs AXTI (6)
Institutional Metric MCHPP AXTI Criterion Row Winner
Market Capitalization Scale N/A $2.9B Larger Scale AXTI
Trailing P/E Ratio Valuation N/M 88.9x Lower Multiple AXTI
Forward P/E Ratio Valuation N/M 16.4x Lower Multiple AXTI
Revenue Growth (YoY) Growth +42.2% +162.6% Higher Growth AXTI
Operating Margin (TTM) Profitability 21.6% 19.6% Higher Margin MCHPP
Net Profit Margin Profitability 15.0% 18.5% Higher Margin AXTI
Return on Equity (ROE) Capital Efficiency 12.6% 6.1% Higher ROE MCHPP
52-Week Range Position Momentum 14% ($47โ€“$88) 22% ($8โ€“$143) Stronger Trend AXTI
Beta / 30D Volatility Risk Regime 2.16ฮฒ ยท 65% Vol 4.37ฮฒ ยท 158% Vol Lower Realized Risk MCHPP
Unified Institutional Score Composite Signal 57.1 / 100 (HOLD) 54.2 / 100 (HOLD) Higher Composite MCHPP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MCHPP vs AXTI Buy Guide
MCHPP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MCHPP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AXTI BREAKDOWN
122d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live AXTI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MCHPP nor AXTI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.